Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.43724284 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.43724284 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.17848489 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.17848489 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.68309162 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.27860063 |
7 | indole-containing compound catabolic process (GO:0042436) | 6.06782028 |
8 | indolalkylamine catabolic process (GO:0046218) | 6.06782028 |
9 | tryptophan catabolic process (GO:0006569) | 6.06782028 |
10 | kynurenine metabolic process (GO:0070189) | 5.97942840 |
11 | bile acid biosynthetic process (GO:0006699) | 5.88753129 |
12 | glyoxylate metabolic process (GO:0046487) | 5.83953389 |
13 | tryptophan metabolic process (GO:0006568) | 5.68091505 |
14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54105288 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50659684 |
16 | negative regulation of fibrinolysis (GO:0051918) | 5.42276146 |
17 | urea metabolic process (GO:0019627) | 5.33425302 |
18 | urea cycle (GO:0000050) | 5.33425302 |
19 | regulation of plasminogen activation (GO:0010755) | 5.31929858 |
20 | cysteine metabolic process (GO:0006534) | 5.29932685 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.23269552 |
22 | regulation of fibrinolysis (GO:0051917) | 5.21090461 |
23 | complement activation, alternative pathway (GO:0006957) | 5.18550977 |
24 | regulation of protein activation cascade (GO:2000257) | 5.16247608 |
25 | protein carboxylation (GO:0018214) | 5.14413273 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.14413273 |
27 | protein-lipid complex assembly (GO:0065005) | 5.05653509 |
28 | serine family amino acid catabolic process (GO:0009071) | 5.01080675 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97615842 |
30 | bile acid metabolic process (GO:0008206) | 4.97457471 |
31 | regulation of cholesterol esterification (GO:0010872) | 4.93792769 |
32 | nitrogen cycle metabolic process (GO:0071941) | 4.92617697 |
33 | negative regulation of protein activation cascade (GO:2000258) | 4.91552755 |
34 | regulation of triglyceride catabolic process (GO:0010896) | 4.89478580 |
35 | aromatic amino acid family metabolic process (GO:0009072) | 4.85190238 |
36 | regulation of complement activation (GO:0030449) | 4.82412266 |
37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.78413172 |
38 | protein-lipid complex remodeling (GO:0034368) | 4.78413172 |
39 | macromolecular complex remodeling (GO:0034367) | 4.78413172 |
40 | reverse cholesterol transport (GO:0043691) | 4.75046966 |
41 | lysine catabolic process (GO:0006554) | 4.74714464 |
42 | lysine metabolic process (GO:0006553) | 4.74714464 |
43 | regulation of apoptotic cell clearance (GO:2000425) | 4.64774229 |
44 | alpha-amino acid catabolic process (GO:1901606) | 4.61659476 |
45 | phospholipid efflux (GO:0033700) | 4.61351490 |
46 | protein-lipid complex subunit organization (GO:0071825) | 4.60346148 |
47 | homocysteine metabolic process (GO:0050667) | 4.59294188 |
48 | glycine metabolic process (GO:0006544) | 4.57464582 |
49 | intestinal absorption (GO:0050892) | 4.55405945 |
50 | negative regulation of cholesterol transport (GO:0032375) | 4.53824783 |
51 | negative regulation of sterol transport (GO:0032372) | 4.53824783 |
52 | amino-acid betaine metabolic process (GO:0006577) | 4.51775486 |
53 | epoxygenase P450 pathway (GO:0019373) | 4.50630388 |
54 | acylglycerol homeostasis (GO:0055090) | 4.50405814 |
55 | triglyceride homeostasis (GO:0070328) | 4.50405814 |
56 | coenzyme catabolic process (GO:0009109) | 4.50243874 |
57 | tyrosine metabolic process (GO:0006570) | 4.49567875 |
58 | cellular ketone body metabolic process (GO:0046950) | 4.45582522 |
59 | regulation of bile acid biosynthetic process (GO:0070857) | 4.40121977 |
60 | acute-phase response (GO:0006953) | 4.40094740 |
61 | plasma lipoprotein particle clearance (GO:0034381) | 4.31364282 |
62 | negative regulation of complement activation (GO:0045916) | 4.30425753 |
63 | cellular amino acid catabolic process (GO:0009063) | 4.27376796 |
64 | bile acid and bile salt transport (GO:0015721) | 4.26581454 |
65 | serine family amino acid metabolic process (GO:0009069) | 4.25188223 |
66 | indolalkylamine metabolic process (GO:0006586) | 4.25012901 |
67 | cellular biogenic amine catabolic process (GO:0042402) | 4.21672008 |
68 | amine catabolic process (GO:0009310) | 4.21672008 |
69 | serine family amino acid biosynthetic process (GO:0009070) | 4.18065769 |
70 | imidazole-containing compound metabolic process (GO:0052803) | 4.17550821 |
71 | negative regulation of hemostasis (GO:1900047) | 4.15338365 |
72 | negative regulation of blood coagulation (GO:0030195) | 4.15338365 |
73 | benzene-containing compound metabolic process (GO:0042537) | 4.15191271 |
74 | cellular modified amino acid catabolic process (GO:0042219) | 4.11128181 |
75 | proline metabolic process (GO:0006560) | 4.10343315 |
76 | cholesterol efflux (GO:0033344) | 4.09938142 |
77 | ethanol oxidation (GO:0006069) | 4.08053382 |
78 | glutamate metabolic process (GO:0006536) | 4.07676712 |
79 | cellular glucuronidation (GO:0052695) | 4.05664165 |
80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.99381710 |
81 | plasma lipoprotein particle assembly (GO:0034377) | 3.95748507 |
82 | cholesterol transport (GO:0030301) | 3.94734611 |
83 | sterol transport (GO:0015918) | 3.94734611 |
84 | regulation of humoral immune response (GO:0002920) | 3.94317194 |
85 | regulation of cholesterol homeostasis (GO:2000188) | 3.93935333 |
86 | negative regulation of coagulation (GO:0050819) | 3.91480042 |
87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.91415484 |
88 | positive regulation of blood coagulation (GO:0030194) | 3.89791040 |
89 | positive regulation of hemostasis (GO:1900048) | 3.89791040 |
90 | intestinal cholesterol absorption (GO:0030299) | 3.86858856 |
91 | sterol homeostasis (GO:0055092) | 3.85034353 |
92 | ketone body metabolic process (GO:1902224) | 3.84925658 |
93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84747709 |
94 | cofactor catabolic process (GO:0051187) | 3.83438019 |
95 | aldehyde catabolic process (GO:0046185) | 3.82768246 |
96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81318924 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81318924 |
98 | arginine metabolic process (GO:0006525) | 3.80413549 |
99 | carboxylic acid catabolic process (GO:0046395) | 3.80309074 |
100 | organic acid catabolic process (GO:0016054) | 3.80309074 |
101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.78240087 |
102 | fibrinolysis (GO:0042730) | 3.76076093 |
103 | short-chain fatty acid metabolic process (GO:0046459) | 3.75454403 |
104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75403324 |
105 | negative regulation of lipase activity (GO:0060192) | 3.70733647 |
106 | complement activation, classical pathway (GO:0006958) | 3.69866143 |
107 | aspartate family amino acid catabolic process (GO:0009068) | 3.69288295 |
108 | positive regulation of lipid catabolic process (GO:0050996) | 3.69006304 |
109 | negative regulation of wound healing (GO:0061045) | 3.68804908 |
110 | drug catabolic process (GO:0042737) | 3.68737687 |
111 | acetyl-CoA metabolic process (GO:0006084) | 3.68381372 |
112 | lipoprotein metabolic process (GO:0042157) | 3.67423526 |
113 | cholesterol homeostasis (GO:0042632) | 3.65132658 |
114 | NAD biosynthetic process (GO:0009435) | 3.63759075 |
115 | complement activation (GO:0006956) | 3.63440599 |
116 | ethanol metabolic process (GO:0006067) | 3.62865726 |
117 | exogenous drug catabolic process (GO:0042738) | 3.62691144 |
118 | 2-oxoglutarate metabolic process (GO:0006103) | 3.62174492 |
119 | cytolysis (GO:0019835) | 3.61981196 |
120 | protein activation cascade (GO:0072376) | 3.60869962 |
121 | plasma lipoprotein particle organization (GO:0071827) | 3.60709684 |
122 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59424993 |
123 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59424993 |
124 | heme transport (GO:0015886) | 3.58203782 |
125 | glucuronate metabolic process (GO:0019585) | 3.58007333 |
126 | uronic acid metabolic process (GO:0006063) | 3.58007333 |
127 | positive regulation of coagulation (GO:0050820) | 3.57054110 |
128 | omega-hydroxylase P450 pathway (GO:0097267) | 3.53005765 |
129 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.49287064 |
130 | positive regulation of steroid metabolic process (GO:0045940) | 3.47621092 |
131 | peptidyl-glutamic acid modification (GO:0018200) | 3.40372498 |
132 | phenylpropanoid metabolic process (GO:0009698) | 3.38594078 |
133 | diacylglycerol metabolic process (GO:0046339) | 3.38117151 |
134 | lipid homeostasis (GO:0055088) | 3.33586454 |
135 | negative regulation of humoral immune response (GO:0002921) | 3.29415852 |
136 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.29286927 |
137 | acute inflammatory response (GO:0002526) | 3.26622998 |
138 | drug metabolic process (GO:0017144) | 3.09284750 |
139 | negative regulation of digestive system process (GO:0060457) | 3.06705858 |
140 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.04010404 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.19183557 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.15985673 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92941147 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.26603428 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.37155344 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19283918 |
7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.07875228 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06990188 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83157848 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30017138 |
11 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11376921 |
12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8375729 |
13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99361092 |
14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.89597852 |
15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82140622 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55998646 |
17 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.53997411 |
18 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50739795 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45963246 |
20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43758815 |
21 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.42826806 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34587405 |
23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33603620 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32911097 |
25 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31461504 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27112512 |
27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.25560325 |
28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23863884 |
29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20467641 |
30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19952387 |
31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18373854 |
32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11527536 |
33 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04922962 |
34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01878102 |
35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00357353 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96688023 |
37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95104573 |
38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95102431 |
39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94155586 |
40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93906830 |
41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91051891 |
42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90824561 |
43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89902787 |
44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89786604 |
45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86690820 |
46 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83926409 |
47 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82340608 |
48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82067129 |
49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81670105 |
50 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81371761 |
51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.79267083 |
52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78552668 |
53 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76579827 |
54 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.76257085 |
55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75971036 |
56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75801259 |
57 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.75289737 |
58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.75119765 |
59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.74461294 |
60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73793455 |
61 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.73699353 |
62 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73687366 |
63 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72821408 |
64 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.72412444 |
65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72248708 |
66 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71954358 |
67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.70770907 |
68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69697483 |
69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69559601 |
70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69161771 |
71 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.68663321 |
72 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68630046 |
73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.68618757 |
74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68225319 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67422922 |
76 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.67031594 |
77 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.66519208 |
78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66376241 |
79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.66336412 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66314659 |
81 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63092131 |
82 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.62971614 |
83 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.61578505 |
84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61387500 |
85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61274993 |
86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.61210338 |
87 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60695132 |
88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.60133674 |
89 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.60128943 |
90 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.59988919 |
91 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.59814923 |
92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58905487 |
93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58810561 |
94 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.58517246 |
95 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.57873370 |
96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57831292 |
97 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.57466850 |
98 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.57386929 |
99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.56731179 |
100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56021955 |
101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.55902597 |
102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.55754249 |
103 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.55593492 |
104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.55285199 |
105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.55212110 |
106 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.53949759 |
107 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53944325 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53886051 |
109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.53181536 |
110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.53135450 |
111 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51484882 |
112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48939072 |
113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.48824807 |
114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47910462 |
115 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.47338367 |
116 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47053145 |
117 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46421698 |
118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46066512 |
119 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.45931119 |
120 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45579823 |
121 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.45354335 |
122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.45001168 |
123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44742547 |
124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.44498064 |
125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.43582041 |
126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42437837 |
127 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.42338152 |
128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.42169915 |
129 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41708692 |
130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41101848 |
131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41101277 |
132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.40957965 |
133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.40815010 |
134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.40567934 |
135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.40567934 |
136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.40322203 |
137 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.39944461 |
138 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39914357 |
139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39417967 |
140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39151450 |
141 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.39010123 |
142 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38934966 |
143 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.38778640 |
144 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.38316495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.20636951 |
2 | MP0005360_urolithiasis | 7.25842363 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.40374069 |
4 | * MP0005365_abnormal_bile_salt | 6.21615835 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87437141 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.34164585 |
7 | MP0003252_abnormal_bile_duct | 3.82288217 |
8 | MP0003122_maternal_imprinting | 3.61752248 |
9 | MP0005083_abnormal_biliary_tract | 3.48023974 |
10 | * MP0010329_abnormal_lipoprotein_level | 3.40446677 |
11 | MP0009840_abnormal_foam_cell | 3.31988434 |
12 | * MP0001666_abnormal_nutrient_absorption | 2.85385145 |
13 | MP0005332_abnormal_amino_acid | 2.75506969 |
14 | MP0003195_calcinosis | 2.73841303 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.33303286 |
16 | * MP0000609_abnormal_liver_physiology | 2.11317293 |
17 | * MP0002118_abnormal_lipid_homeostasis | 2.10501647 |
18 | MP0003868_abnormal_feces_composition | 2.00697523 |
19 | MP0004019_abnormal_vitamin_homeostasis | 1.90422563 |
20 | * MP0005319_abnormal_enzyme/_coenzyme | 1.87648014 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.87612400 |
22 | MP0003172_abnormal_lysosome_physiology | 1.86733756 |
23 | MP0003123_paternal_imprinting | 1.86514012 |
24 | MP0001764_abnormal_homeostasis | 1.77187356 |
25 | MP0009780_abnormal_chondrocyte_physiolo | 1.75710712 |
26 | MP0000566_synostosis | 1.67467906 |
27 | MP0009697_abnormal_copulation | 1.67016755 |
28 | MP0005379_endocrine/exocrine_gland_phen | 1.65274680 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60935574 |
30 | MP0002089_abnormal_postnatal_growth/wei | 1.55892730 |
31 | MP0002132_abnormal_respiratory_system | 1.53511138 |
32 | MP0005451_abnormal_body_composition | 1.45665161 |
33 | MP0003186_abnormal_redox_activity | 1.41476040 |
34 | MP0002909_abnormal_adrenal_gland | 1.38208425 |
35 | MP0009643_abnormal_urine_homeostasis | 1.28867751 |
36 | MP0001915_intracranial_hemorrhage | 1.26986656 |
37 | MP0003011_delayed_dark_adaptation | 1.22228313 |
38 | MP0000598_abnormal_liver_morphology | 1.21213869 |
39 | MP0003656_abnormal_erythrocyte_physiolo | 1.20142918 |
40 | MP0006036_abnormal_mitochondrial_physio | 1.16761892 |
41 | MP0005220_abnormal_exocrine_pancreas | 1.15675857 |
42 | MP0009763_increased_sensitivity_to | 1.05812412 |
43 | MP0009764_decreased_sensitivity_to | 1.04091606 |
44 | MP0010386_abnormal_urinary_bladder | 1.03158681 |
45 | MP0005084_abnormal_gallbladder_morpholo | 1.03143009 |
46 | MP0003705_abnormal_hypodermis_morpholog | 1.00084312 |
47 | MP0005636_abnormal_mineral_homeostasis | 0.98289492 |
48 | MP0010368_abnormal_lymphatic_system | 0.97478633 |
49 | MP0003879_abnormal_hair_cell | 0.97112918 |
50 | MP0005409_darkened_coat_color | 0.96484676 |
51 | MP0003121_genomic_imprinting | 0.96214497 |
52 | MP0000604_amyloidosis | 0.96090754 |
53 | * MP0008469_abnormal_protein_level | 0.95980728 |
54 | * MP0009642_abnormal_blood_homeostasis | 0.90031741 |
55 | MP0000003_abnormal_adipose_tissue | 0.89719903 |
56 | MP0002837_dystrophic_cardiac_calcinosis | 0.87524184 |
57 | MP0005376_homeostasis/metabolism_phenot | 0.85007746 |
58 | MP0002078_abnormal_glucose_homeostasis | 0.84377540 |
59 | MP0000013_abnormal_adipose_tissue | 0.84173573 |
60 | * MP0005647_abnormal_sex_gland | 0.84007174 |
61 | MP0005167_abnormal_blood-brain_barrier | 0.82255465 |
62 | MP0005408_hypopigmentation | 0.81293436 |
63 | MP0009765_abnormal_xenobiotic_induced | 0.78101833 |
64 | MP0005266_abnormal_metabolism | 0.77712855 |
65 | MP0002693_abnormal_pancreas_physiology | 0.77589053 |
66 | MP0004130_abnormal_muscle_cell | 0.76323061 |
67 | MP0003183_abnormal_peptide_metabolism | 0.75140671 |
68 | MP0006035_abnormal_mitochondrial_morpho | 0.75074098 |
69 | MP0002938_white_spotting | 0.74811776 |
70 | MP0004043_abnormal_pH_regulation | 0.72641048 |
71 | MP0005670_abnormal_white_adipose | 0.72467875 |
72 | MP0005646_abnormal_pituitary_gland | 0.71388367 |
73 | MP0002163_abnormal_gland_morphology | 0.71023666 |
74 | MP0002971_abnormal_brown_adipose | 0.70842459 |
75 | MP0005334_abnormal_fat_pad | 0.70540908 |
76 | MP0002254_reproductive_system_inflammat | 0.70531272 |
77 | MP0005535_abnormal_body_temperature | 0.69384655 |
78 | MP0002876_abnormal_thyroid_physiology | 0.69135610 |
79 | MP0006054_spinal_hemorrhage | 0.68033785 |
80 | MP0003943_abnormal_hepatobiliary_system | 0.63375658 |
81 | MP0000639_abnormal_adrenal_gland | 0.61581403 |
82 | MP0010234_abnormal_vibrissa_follicle | 0.59948906 |
83 | MP0005448_abnormal_energy_balance | 0.59701927 |
84 | MP0005464_abnormal_platelet_physiology | 0.58511237 |
85 | MP0001756_abnormal_urination | 0.57962785 |
86 | MP0003638_abnormal_response/metabolism_ | 0.57224925 |
87 | MP0002168_other_aberrant_phenotype | 0.54056934 |
88 | MP0003690_abnormal_glial_cell | 0.53407841 |
89 | MP0001270_distended_abdomen | 0.53251954 |
90 | MP0003329_amyloid_beta_deposits | 0.52014433 |
91 | MP0009053_abnormal_anal_canal | 0.51387402 |
92 | MP0001661_extended_life_span | 0.50131476 |
93 | MP0001765_abnormal_ion_homeostasis | 0.49227478 |
94 | MP0003724_increased_susceptibility_to | 0.48799547 |
95 | MP0008873_increased_physiological_sensi | 0.46307600 |
96 | MP0002928_abnormal_bile_duct | 0.45739444 |
97 | MP0003436_decreased_susceptibility_to | 0.45524183 |
98 | MP0000371_diluted_coat_color | 0.45388479 |
99 | MP0008874_decreased_physiological_sensi | 0.45175083 |
100 | MP0004270_analgesia | 0.44163567 |
101 | MP0002136_abnormal_kidney_physiology | 0.43826740 |
102 | * MP0003953_abnormal_hormone_level | 0.43089894 |
103 | MP0002822_catalepsy | 0.42290055 |
104 | MP0005551_abnormal_eye_electrophysiolog | 0.40989903 |
105 | MP0001853_heart_inflammation | 0.40766796 |
106 | MP0004782_abnormal_surfactant_physiolog | 0.40275558 |
107 | MP0005330_cardiomyopathy | 0.40232039 |
108 | MP0005257_abnormal_intraocular_pressure | 0.39853425 |
109 | MP0005166_decreased_susceptibility_to | 0.38434905 |
110 | MP0000230_abnormal_systemic_arterial | 0.38389084 |
111 | MP0003075_altered_response_to | 0.37507345 |
112 | MP0003633_abnormal_nervous_system | 0.37481962 |
113 | MP0005410_abnormal_fertilization | 0.37277758 |
114 | MP0005666_abnormal_adipose_tissue | 0.37190973 |
115 | MP0001845_abnormal_inflammatory_respons | 0.36584058 |
116 | MP0004264_abnormal_extraembryonic_tissu | 0.36046810 |
117 | MP0003718_maternal_effect | 0.35694881 |
118 | MP0002970_abnormal_white_adipose | 0.35622745 |
119 | MP0004381_abnormal_hair_follicle | 0.35372140 |
120 | MP0002269_muscular_atrophy | 0.35330803 |
121 | MP0005164_abnormal_response_to | 0.34990764 |
122 | MP0005395_other_phenotype | 0.34932530 |
123 | MP0003283_abnormal_digestive_organ | 0.34902860 |
124 | MP0009672_abnormal_birth_weight | 0.34705950 |
125 | MP0008872_abnormal_physiological_respon | 0.34368162 |
126 | MP0009384_cardiac_valve_regurgitation | 0.34164677 |
127 | MP0003959_abnormal_lean_body | 0.33906728 |
128 | MP0000249_abnormal_blood_vessel | 0.33309399 |
129 | MP0009115_abnormal_fat_cell | 0.31158590 |
130 | MP0005058_abnormal_lysosome_morphology | 0.29862183 |
131 | MP0001944_abnormal_pancreas_morphology | 0.29786874 |
132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.29080343 |
133 | MP0000579_abnormal_nail_morphology | 0.29039622 |
134 | MP0005165_increased_susceptibility_to | 0.28576890 |
135 | MP0006082_CNS_inflammation | 0.27429053 |
136 | MP0002796_impaired_skin_barrier | 0.25797316 |
137 | MP0001243_abnormal_dermal_layer | 0.24083021 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23883971 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.04560464 |
3 | Deep venous thrombosis (HP:0002625) | 6.92729606 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.34935698 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.29553806 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.24989714 |
7 | Xanthomatosis (HP:0000991) | 5.88878329 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.35923396 |
9 | Complement deficiency (HP:0004431) | 5.05704683 |
10 | Hypolipoproteinemia (HP:0010981) | 4.60638550 |
11 | Hyperammonemia (HP:0001987) | 4.60465192 |
12 | Joint hemorrhage (HP:0005261) | 4.59560255 |
13 | Ketosis (HP:0001946) | 4.44329858 |
14 | Hyperglycinemia (HP:0002154) | 4.41064428 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35863556 |
16 | Hypoglycemic coma (HP:0001325) | 4.35623497 |
17 | Fat malabsorption (HP:0002630) | 4.25414880 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.21081508 |
19 | Abnormality of methionine metabolism (HP:0010901) | 4.11238827 |
20 | Epidermoid cyst (HP:0200040) | 4.10949633 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.06444012 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95090091 |
23 | Hyperglycinuria (HP:0003108) | 3.94518158 |
24 | Hypoalphalipoproteinemia (HP:0003233) | 3.94443063 |
25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.93053403 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92560564 |
27 | Abnormality of glycine metabolism (HP:0010895) | 3.92560564 |
28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.74457320 |
29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.71950826 |
30 | Abnormality of complement system (HP:0005339) | 3.70221196 |
31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69881323 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.61853064 |
33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.54840861 |
34 | Steatorrhea (HP:0002570) | 3.40731899 |
35 | Hyperbilirubinemia (HP:0002904) | 3.40652594 |
36 | Hypercholesterolemia (HP:0003124) | 3.38674308 |
37 | Ketoacidosis (HP:0001993) | 3.32768353 |
38 | Delayed CNS myelination (HP:0002188) | 3.13688319 |
39 | Abnormality of serum amino acid levels (HP:0003112) | 3.09235522 |
40 | Dicarboxylic aciduria (HP:0003215) | 2.99957244 |
41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.99957244 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99187128 |
43 | Metabolic acidosis (HP:0001942) | 2.88957745 |
44 | Purpura (HP:0000979) | 2.87282669 |
45 | Spontaneous abortion (HP:0005268) | 2.80271819 |
46 | Hepatocellular carcinoma (HP:0001402) | 2.78331747 |
47 | Lethargy (HP:0001254) | 2.75395912 |
48 | Cerebral edema (HP:0002181) | 2.72001471 |
49 | Hypochromic microcytic anemia (HP:0004840) | 2.71992541 |
50 | Myocardial infarction (HP:0001658) | 2.70675574 |
51 | Hydroxyprolinuria (HP:0003080) | 2.64901662 |
52 | Abnormality of proline metabolism (HP:0010907) | 2.64901662 |
53 | Skin nodule (HP:0200036) | 2.64704343 |
54 | Abnormality of purine metabolism (HP:0004352) | 2.63840030 |
55 | Systemic lupus erythematosus (HP:0002725) | 2.60716582 |
56 | Gout (HP:0001997) | 2.60133772 |
57 | Hypoglycemic seizures (HP:0002173) | 2.58229203 |
58 | Generalized aminoaciduria (HP:0002909) | 2.51345071 |
59 | Hypophosphatemic rickets (HP:0004912) | 2.49104944 |
60 | Nephritis (HP:0000123) | 2.48940376 |
61 | Vascular calcification (HP:0004934) | 2.46829387 |
62 | Arthropathy (HP:0003040) | 2.46489192 |
63 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45341807 |
64 | Abnormality of carpal bone ossification (HP:0006257) | 2.45341248 |
65 | Late onset (HP:0003584) | 2.44252878 |
66 | Abnormal gallbladder morphology (HP:0012437) | 2.43606471 |
67 | Acanthocytosis (HP:0001927) | 2.38599535 |
68 | Cholelithiasis (HP:0001081) | 2.38584400 |
69 | Facial shape deformation (HP:0011334) | 2.38132200 |
70 | Potter facies (HP:0002009) | 2.38132200 |
71 | Asymmetry of the thorax (HP:0001555) | 2.37103339 |
72 | Hypothermia (HP:0002045) | 2.34573067 |
73 | Spastic diplegia (HP:0001264) | 2.34200595 |
74 | Mitral stenosis (HP:0001718) | 2.34133441 |
75 | Neonatal onset (HP:0003623) | 2.32082070 |
76 | Small epiphyses (HP:0010585) | 2.31914609 |
77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27675736 |
78 | Amyloidosis (HP:0011034) | 2.24854880 |
79 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24450937 |
80 | Pancreatitis (HP:0001733) | 2.23258759 |
81 | Vomiting (HP:0002013) | 2.21637707 |
82 | Cholecystitis (HP:0001082) | 2.20217065 |
83 | Abnormal gallbladder physiology (HP:0012438) | 2.20217065 |
84 | Broad alveolar ridges (HP:0000187) | 2.19492776 |
85 | Irritability (HP:0000737) | 2.19257373 |
86 | Rickets (HP:0002748) | 2.18377325 |
87 | Glomerulonephritis (HP:0000099) | 2.18230286 |
88 | Cardiovascular calcification (HP:0011915) | 2.17253870 |
89 | Gingival bleeding (HP:0000225) | 2.17120138 |
90 | Brushfield spots (HP:0001088) | 2.16992008 |
91 | Opisthotonus (HP:0002179) | 2.16801803 |
92 | Increased serum pyruvate (HP:0003542) | 2.16602361 |
93 | Malnutrition (HP:0004395) | 2.14324798 |
94 | Abnormal tarsal ossification (HP:0008369) | 2.13700314 |
95 | Vaginal fistula (HP:0004320) | 2.10343798 |
96 | Renal cortical cysts (HP:0000803) | 2.08141540 |
97 | Thrombophlebitis (HP:0004418) | 2.07469581 |
98 | Esophageal varix (HP:0002040) | 2.07028559 |
99 | Menorrhagia (HP:0000132) | 2.03550050 |
100 | Sensorimotor neuropathy (HP:0007141) | 1.99853262 |
101 | Abnormality of the nasal septum (HP:0000419) | 1.98925378 |
102 | Enlarged kidneys (HP:0000105) | 1.96606059 |
103 | Abnormality of iron homeostasis (HP:0011031) | 1.96325719 |
104 | Poikilocytosis (HP:0004447) | 1.95785997 |
105 | Abnormality of the gallbladder (HP:0005264) | 1.95524681 |
106 | Proximal tubulopathy (HP:0000114) | 1.95408401 |
107 | Abnormality of glycolysis (HP:0004366) | 1.94419402 |
108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93397167 |
109 | Mucopolysacchariduria (HP:0008155) | 1.91060891 |
110 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91060891 |
111 | Elevated hepatic transaminases (HP:0002910) | 1.89595270 |
112 | Abnormality of urine glucose concentration (HP:0011016) | 1.88394943 |
113 | Glycosuria (HP:0003076) | 1.88394943 |
114 | Widely patent fontanelles and sutures (HP:0004492) | 1.87472838 |
115 | Hemorrhage of the eye (HP:0011885) | 1.86253022 |
116 | Abnormal cartilage morphology (HP:0002763) | 1.86244451 |
117 | Pulmonary embolism (HP:0002204) | 1.84538549 |
118 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.83872765 |
119 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.83872765 |
120 | Hepatoblastoma (HP:0002884) | 1.83667742 |
121 | Abnormal hand bone ossification (HP:0010660) | 1.81282489 |
122 | Nausea (HP:0002018) | 1.81072029 |
123 | Hepatic necrosis (HP:0002605) | 1.80061181 |
124 | Hyperglycemia (HP:0003074) | 1.78710964 |
125 | Abnormality of the vitreous humor (HP:0004327) | 1.77213075 |
126 | Osteomalacia (HP:0002749) | 1.76840652 |
127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75027468 |
128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75027468 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75027468 |
130 | Ragged-red muscle fibers (HP:0003200) | 1.73527473 |
131 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.70085716 |
132 | Acute hepatic failure (HP:0006554) | 1.69922796 |
133 | Abnormality of the Achilles tendon (HP:0005109) | 1.69787381 |
134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.69359680 |
135 | Abnormality of vitamin metabolism (HP:0100508) | 1.68770232 |
136 | Impaired pain sensation (HP:0007328) | 1.66702532 |
137 | Abnormality of pain sensation (HP:0010832) | 1.66702532 |
138 | Bifid scrotum (HP:0000048) | 1.65507058 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 8.36783267 |
2 | FGFR3 | 5.13985075 |
3 | ERN1 | 4.75872207 |
4 | WNK4 | 4.21228965 |
5 | SIK1 | 3.94698690 |
6 | FGFR4 | 3.92507404 |
7 | TAOK3 | 3.07475662 |
8 | LMTK2 | 3.00739371 |
9 | PKN2 | 2.75992406 |
10 | FLT3 | 2.56102732 |
11 | INSRR | 2.53327655 |
12 | ERBB4 | 2.24460448 |
13 | MAP2K4 | 2.09024286 |
14 | AKT3 | 2.04420551 |
15 | TRIB3 | 2.04335373 |
16 | STK24 | 1.90517864 |
17 | PIK3CG | 1.85093106 |
18 | NTRK3 | 1.78745713 |
19 | MAPK11 | 1.77092821 |
20 | MAP2K3 | 1.74375375 |
21 | TYK2 | 1.71064258 |
22 | FGFR1 | 1.68211187 |
23 | CDK12 | 1.64100402 |
24 | MST1R | 1.61727050 |
25 | KDR | 1.54587685 |
26 | ABL2 | 1.54141364 |
27 | TYRO3 | 1.50037303 |
28 | EPHA2 | 1.39540590 |
29 | WNK1 | 1.38621684 |
30 | MAP3K2 | 1.34693612 |
31 | PINK1 | 1.30607408 |
32 | PDGFRA | 1.30025235 |
33 | NEK9 | 1.26016638 |
34 | PTK6 | 1.24378703 |
35 | DAPK2 | 1.23723105 |
36 | TBK1 | 1.20670380 |
37 | TIE1 | 1.18878371 |
38 | SIK2 | 1.12332223 |
39 | FRK | 1.07232727 |
40 | STK16 | 1.07058963 |
41 | MAP2K6 | 1.06614443 |
42 | JAK2 | 1.06335948 |
43 | MAP4K2 | 1.06139691 |
44 | IRAK3 | 1.05799006 |
45 | MAP3K6 | 1.05466952 |
46 | MAP3K7 | 1.00658530 |
47 | MAPK15 | 1.00439687 |
48 | PRKAA2 | 0.98576512 |
49 | STK39 | 0.97738366 |
50 | MAPK4 | 0.94503256 |
51 | PRKG2 | 0.94027958 |
52 | MYLK | 0.93308091 |
53 | MAP3K11 | 0.90937554 |
54 | SGK494 | 0.88055802 |
55 | SGK223 | 0.88055802 |
56 | SGK1 | 0.87445646 |
57 | MAP3K3 | 0.85734806 |
58 | MAPK12 | 0.84033868 |
59 | GRK6 | 0.82963182 |
60 | LATS1 | 0.81914889 |
61 | NLK | 0.80752311 |
62 | FER | 0.79409853 |
63 | RIPK1 | 0.75935589 |
64 | JAK1 | 0.75315091 |
65 | MST4 | 0.74463210 |
66 | ERBB2 | 0.74460452 |
67 | EIF2AK1 | 0.73509970 |
68 | SGK3 | 0.72421343 |
69 | TGFBR2 | 0.72387819 |
70 | PIK3CA | 0.71150151 |
71 | PHKG2 | 0.71013088 |
72 | PHKG1 | 0.71013088 |
73 | KIT | 0.70149020 |
74 | DDR2 | 0.69709642 |
75 | SGK2 | 0.68526327 |
76 | PRKACG | 0.68157006 |
77 | MAP3K9 | 0.67904229 |
78 | CSNK1E | 0.67876836 |
79 | MAP3K14 | 0.67792701 |
80 | CDC42BPA | 0.67196351 |
81 | DYRK1B | 0.66479001 |
82 | MAP3K5 | 0.64967793 |
83 | MAP3K10 | 0.64082591 |
84 | PRKG1 | 0.63446718 |
85 | CAMK2G | 0.63145708 |
86 | CSF1R | 0.63099504 |
87 | PRKCZ | 0.62096379 |
88 | OBSCN | 0.62084577 |
89 | PRKAA1 | 0.59300341 |
90 | PRKCG | 0.58746405 |
91 | ZAP70 | 0.58362888 |
92 | NME2 | 0.58283854 |
93 | FGFR2 | 0.57415366 |
94 | PDK2 | 0.57274269 |
95 | PDK3 | 0.56279030 |
96 | PDK4 | 0.56279030 |
97 | IKBKE | 0.55692718 |
98 | CDK6 | 0.51922011 |
99 | EPHB1 | 0.51674398 |
100 | TAOK1 | 0.51254563 |
101 | CDK4 | 0.49459438 |
102 | CSK | 0.48661384 |
103 | RPS6KB1 | 0.48260816 |
104 | MAP3K1 | 0.47203000 |
105 | HIPK2 | 0.46608391 |
106 | EEF2K | 0.46586825 |
107 | EPHA4 | 0.46546662 |
108 | STK38L | 0.45356215 |
109 | CSNK1D | 0.44518845 |
110 | BCR | 0.43586084 |
111 | GSK3A | 0.42969872 |
112 | CAMK1D | 0.42813941 |
113 | CAMK4 | 0.42133604 |
114 | PDPK1 | 0.42121139 |
115 | CAMK2D | 0.40314473 |
116 | PRKACA | 0.39827115 |
117 | BTK | 0.39442993 |
118 | ACVR1B | 0.38539953 |
119 | PRKCQ | 0.38355991 |
120 | PTK2 | 0.38065163 |
121 | MAP4K1 | 0.37747729 |
122 | FGR | 0.37743885 |
123 | MAPKAPK3 | 0.36044326 |
124 | STK38 | 0.35822239 |
125 | IGF1R | 0.35581010 |
126 | CSNK1G1 | 0.35193563 |
127 | EPHA3 | 0.34659374 |
128 | EIF2AK3 | 0.34599653 |
129 | MAP2K2 | 0.34212952 |
130 | PRKCE | 0.34037330 |
131 | MAPK7 | 0.33657140 |
132 | NEK1 | 0.32890462 |
133 | TAOK2 | 0.32724612 |
134 | RPS6KA3 | 0.31755733 |
135 | MET | 0.31431584 |
136 | SRC | 0.31314755 |
137 | CDK7 | 0.30939735 |
138 | PDK1 | 0.30314696 |
139 | CSNK2A2 | 0.29780783 |
140 | CAMK1G | 0.29760506 |
141 | RET | 0.29691415 |
142 | MAP2K1 | 0.29627026 |
143 | TEC | 0.28604128 |
144 | MAP3K13 | 0.28460966 |
145 | TRPM7 | 0.27797704 |
146 | GRK1 | 0.27760178 |
147 | STK3 | 0.27494443 |
148 | CSNK1G3 | 0.27098801 |
149 | PRKACB | 0.25801783 |
150 | MTOR | 0.23523591 |
151 | EGFR | 0.22576612 |
152 | ICK | 0.22275156 |
153 | TGFBR1 | 0.21416998 |
154 | ITK | 0.20920669 |
155 | PRKCA | 0.20153482 |
156 | TTN | 0.19976862 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47349090 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29932392 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24122836 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14523537 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90012001 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68600841 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66906518 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62901025 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61478980 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60120580 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57329051 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52849235 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19142997 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.13512767 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10205867 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10192209 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08975936 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91285641 |
19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88830980 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83993882 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83875933 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82751201 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81294943 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78636010 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75785238 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73464246 |
27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68324176 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67149832 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62308975 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61660899 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60063021 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59823638 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59590628 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56856583 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52083954 |
36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48561152 |
37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45364207 |
38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41756236 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39676715 |
40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39072572 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38200488 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37006049 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34599165 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30984630 |
45 | * Bile secretion_Homo sapiens_hsa04976 | 1.30386630 |
46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28045113 |
47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26247738 |
48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14257196 |
49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11798340 |
50 | ABC transporters_Homo sapiens_hsa02010 | 1.11286063 |
51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11062295 |
52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08016691 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02850876 |
54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02061319 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96230498 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94055742 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89910162 |
58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88621624 |
59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88091096 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87331833 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79768245 |
62 | Lysine degradation_Homo sapiens_hsa00310 | 0.78291505 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75731116 |
64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73932836 |
65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72434112 |
66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72244785 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66491114 |
68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52907735 |
69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50842157 |
70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47968913 |
71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44998172 |
72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43651514 |
73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41379720 |
74 | Mineral absorption_Homo sapiens_hsa04978 | 0.38144903 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36441997 |
76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35823787 |
77 | Prion diseases_Homo sapiens_hsa05020 | 0.30067430 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28378380 |
79 | Pertussis_Homo sapiens_hsa05133 | 0.27365200 |
80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26868068 |
81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25752779 |
82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23354062 |
83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22051782 |
84 | Insulin resistance_Homo sapiens_hsa04931 | 0.20507529 |
85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18880511 |
86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16485707 |
87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08588875 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08533123 |
89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07751030 |
90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06866758 |
91 | Insulin secretion_Homo sapiens_hsa04911 | 0.03430104 |
92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.02873156 |
93 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1904087 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1876173 |
95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1776577 |
96 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1616308 |
97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1503917 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1438746 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1381109 |
100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1339670 |
101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1333985 |
102 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1294070 |
103 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1292672 |
104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1246055 |
105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1203836 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1194427 |
107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1088133 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1069523 |
109 | Protein export_Homo sapiens_hsa03060 | -0.0816539 |
110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0797467 |
111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0552795 |
112 | Lysosome_Homo sapiens_hsa04142 | -0.0200347 |
113 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0087584 |